Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease
Authors:
- Simon RosenstielSRSimon Rosenstiel
- Paul SchnitzlerPSPaul Schnitzler
- Ulf HinzUHUlf Hinz
- Tobias RehlenTRTobias Rehlen
- Martina KadmonMKMartina Kadmon
- Robert EhehaltRERobert Ehehalt
- Wolfgang StremmelWSWolfgang Stremmel
- Anna ZawieruchaAZAnna Zawierucha
- 1 June 2015
- journal article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 27 (6) , 712-720
Abstract
This 10-year retrospective cohort study aims to determine the prevalence and risk factors of cytomegalovirus (CMV) infection in inpatients with exacerbated inflammatory bowel disease (IBD). All patients admitted to the Department of Gastroenterology of the University Hospital Heidelberg for IBD exacerbation between January 2004 and June 2013 were enrolled. To identify the risk factors of CMV infection, infected individuals were compared with those with excluded infection. Among 297 patients with exacerbated IBD, 21 had confirmed CMV infection and 79 had excluded CMV infection, whereas the remaining patients had not been sufficiently tested for CMV. Taking into account only sufficiently tested individuals, the prevalence of CMV infection was 22.7% in ulcerative colitis and 16.0% in Crohn's disease. The occurrence of CMV infection was associated with the following variables at admission: age of 30 years or more [odds ratio (OR) 14.29; P=0.004], disease duration less than 60 months (OR 7.69; P=0.011), a blood leukocyte count less than 11/nl (OR 4.49; P=0.041), and immunosuppressive therapy (OR 6.73; P=0.0129). CMV-positive patients remained in the hospital longer than noninfected patients (P=0.0009). In the CMV-positive cohort, a 66-year-old woman died of CMV pneumonia and sepsis, whereas there was no death in the CMV-negative cohort. Immunuosuppressive therapy and age older than 30 years were identified as the main risk factors for the development of CMV infection in exacerbated IBD. Because of the risk of death, diagnostics of CMV infection should especially be initiated in older patients on immunosuppressive therapy.Keywords
This publication has 21 references indexed in Scilit:
- Antiviral therapy in cytomegalovirus-positive ulcerative colitis: A systematic review and meta-analysisWorld Journal of Gastroenterology, 2014
- Management of cytomegalovirus infection in inflammatory bowel diseasesDigestive and Liver Disease, 2012
- Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative ColitisAmerican Journal of Gastroenterology, 2011
- Cytomegalovirus Is Frequently Reactivated and Disappears Without Antiviral Agents in Ulcerative Colitis PatientsAmerican Journal of Gastroenterology, 2007
- Cytomegalovirus Colitis Complicating Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2006
- Prevalence of Cytomegalovirus Infection in Inflammatory Bowel Disease PatientsDiseases of the Colon & Rectum, 2004
- Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature2004
- Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitisAmerican Journal of Gastroenterology, 2001
- Cytomegalovirus Infection in Patients With Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 1999
- Cytomegalic inclusion disease and ulcerative colitisThe American Journal of Medicine, 1961